Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00184652 |
Recruitment Status
:
Completed
First Posted
: September 16, 2005
Last Update Posted
: January 24, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Kidney Disease End-Stage Renal Disease | Drug: somatropin | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 140 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | The Effect of Norditropin® on Nutritional Status in Adult Patients in Chronic Haemodialysis |
Study Start Date : | April 2003 |
Actual Primary Completion Date : | September 2005 |
Actual Study Completion Date : | September 2005 |

- Change in surrogate markers of nutrition [ Time Frame: After 6 months treatment ]
- Quality of Life
- Other markers of nutrition

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 99 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ESRD patients
Exclusion Criteria:
- Diabetes Mellitus
- Severe and Malignant diseases
- Patients in Intensive Care Units

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00184652
Denmark | |
Novo Nordisk Investigational Site | |
København Ø, Denmark, 2100 | |
Novo Nordisk Investigational Site | |
Odense, Denmark, 5000 | |
Novo Nordisk Investigational Site | |
Århus N, Denmark, 8200 | |
Germany | |
Novo Nordisk Investigational Site | |
Berlin, Germany, 13353 | |
Novo Nordisk Investigational Site | |
Heidelberg, Germany, 69115 | |
Hong Kong | |
Novo Nordisk Investigational Site | |
Hong Kong, Hong Kong | |
Israel | |
Novo Nordisk Investigational Site | |
Holon, Israel, 58100 | |
Novo Nordisk Investigational Site | |
Kfar Saba, Israel, 44281 | |
Novo Nordisk Investigational Site | |
Petach Tikva, Israel, 49100 | |
Novo Nordisk Investigational Site | |
Ramat Gan, Israel, 52621 | |
Novo Nordisk Investigational Site | |
Tel-Aviv, Israel, 64239 | |
Novo Nordisk Investigational Site | |
Tzriffin, Israel, 70300 | |
Poland | |
Novo Nordisk Investigational Site | |
Krakow, Poland, 31-501 | |
Novo Nordisk Investigational Site | |
Lublin, Poland, 20 - 094 | |
Novo Nordisk Investigational Site | |
Wolomin, Poland, 05-200 | |
Singapore | |
Novo Nordisk Investigational Site | |
Singapore, Singapore, 119074 | |
Sweden | |
Novo Nordisk Investigational Site | |
Göteborg, Sweden, 417 17 | |
Switzerland | |
Novo Nordisk Investigational Site | |
Bern, Switzerland, 3010 | |
United Kingdom | |
Novo Nordisk Investigational Site | |
Birmingham, United Kingdom, B9 5SS | |
Novo Nordisk Investigational Site | |
Coventry, United Kingdom, CV2 2DX | |
Novo Nordisk Investigational Site | |
Glasgow, United Kingdom, G11 6NT | |
Novo Nordisk Investigational Site | |
Liverpool, United Kingdom, L69 3GA | |
Novo Nordisk Investigational Site | |
Manchester, United Kingdom, M13 0HZ | |
Novo Nordisk Investigational Site | |
Newcastle, United Kingdom, NE7 7DN | |
Novo Nordisk Investigational Site | |
Sheffield, United Kingdom, S5 7AU | |
Novo Nordisk Investigational Site | |
Swansea, United Kingdom, SA6 6NL |
Study Director: | Global Clinical Registry (GCR 1452) | Novo Nordisk A/S |
Additional Information:
Publications of Results:
Responsible Party: | Novo Nordisk A/S |
ClinicalTrials.gov Identifier: | NCT00184652 History of Changes |
Other Study ID Numbers: |
NN1606-1442 |
First Posted: | September 16, 2005 Key Record Dates |
Last Update Posted: | January 24, 2017 |
Last Verified: | January 2017 |
Additional relevant MeSH terms:
Kidney Diseases Renal Insufficiency, Chronic Kidney Failure, Chronic Urologic Diseases Renal Insufficiency |